Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current methods for optimal insulin therapy]

J L Selam1, G Slama

  • 1Service de Diabétologie, INSERM U.341, Hôtel-Dieu, Paris.

Annales D'Endocrinologie
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes.

Diabetes & metabolism·2011
Same author

Therapeutic alliance and glycaemic control in type 1 diabetes: a pilot study.

Diabetes & metabolism·2010
Same author

Peak-time determination of post-meal glucose excursions in insulin-treated diabetic patients.

Diabetes & metabolism·2010
Same author

Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients.

Diabetes & metabolism·2009
Same author

Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres.

Diabetes & metabolism·2009
Same author

Glycaemic index methodology.

Nutrition research reviews·2008
Same journal

[18F]F-DOPA and [18F]F-FDG PET/CT for staging advanced medullary thyroid cancer.

Annales d'endocrinologie·2026
Same journal

Corrigendum to 'Pink adipose tissue: A paradigm of adipose tissue plasticity' [Ann. Endocrinol. 85 (2004) 248-51].

Annales d'endocrinologie·2026
Same journal

Intraoperative location of parathyroid glands during total thyroidectomy: a systematic review of the literature according to the PRISMA method.

Annales d'endocrinologie·2026
Same journal

Clinical and genetic diagnosis of PHP1A associated with hypogonadism in a young male: A case report.

Annales d'endocrinologie·2026
Same journal

Autoimmune features in acquired generalized lipodystrophy and anti-perilipin 1 antibodies: A case report.

Annales d'endocrinologie·2026
Same journal

The diagnostic challenge of occult glucocorticoid exposure causing Cushing's syndrome.

Annales d'endocrinologie·2026
See all related articles

Optimizing insulin therapy is crucial for reducing diabetes mellitus microvascular risks. Enhancements in patient motivation, follow-up frequency, and insulin delivery systems are key to improving blood glucose control.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Mellitus Research

Context:

  • The Diabetes Control and Complications Trial (DCCT) established the necessity of optimizing insulin therapy.
  • Current therapeutic strategies require refinement to effectively manage diabetes mellitus.
  • Advances in diabetes management necessitate updates to existing treatment protocols.

Purpose:

  • To explore essential improvements in insulin therapy for diabetes mellitus.
  • To enhance methods for optimizing blood glucose control in diabetic patients.
  • To leverage recent advancements for better diabetes management outcomes.

Summary:

  • Optimizing insulin therapy involves enhancing patient motivation and follow-up frequency through multidisciplinary consultations.

Related Experiment Videos

  • Utilizing rapid glycosylated hemoglobin assays and computerized glucose meters can improve blood glucose monitoring.
  • Advancements in insulin delivery, including ultra-rapid analogues and insulin pumps, are vital for achieving normal blood glucose levels, despite potential hypoglycemia risks.

    • Impact:

    • Improved microvascular risk reduction in patients with diabetes mellitus.
    • Potential for better patient adherence and quality of life through enhanced motivation and comfort.
    • Development of cost-effective and less burdensome insulin therapy strategies.